New type of biomarker shows promise in improving prostate cancer care

Two biomarkers have been discovered by researchers that may improve oncologists’ ability to predict which patients’ prostate cancer will recur after surgery, long before the development of visible cancer elsewhere in the body. (Mehr in: Cancer News — ScienceDaily)